Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity.

Hilton HG, Rubinstein ND, Janki P, Ireland AT, Bernstein N, Fong NL, Wright KM, Smith M, Finkle D, Martin-McNulty B, Roy M, Imai DM, Jojic V, Buffenstein R.

PLoS Biol. 2019 Nov 21;17(11):e3000528. doi: 10.1371/journal.pbio.3000528. eCollection 2019 Nov.

2.

RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.

Newton K, Dugger DL, Maltzman A, Greve JM, Hedehus M, Martin-McNulty B, Carano RA, Cao TC, van Bruggen N, Bernstein L, Lee WP, Wu X, DeVoss J, Zhang J, Jeet S, Peng I, McKenzie BS, Roose-Girma M, Caplazi P, Diehl L, Webster JD, Vucic D.

Cell Death Differ. 2016 Sep 1;23(9):1565-76. doi: 10.1038/cdd.2016.46. Epub 2016 May 13.

3.

Death receptors DR6 and TROY regulate brain vascular development.

Tam SJ, Richmond DL, Kaminker JS, Modrusan Z, Martin-McNulty B, Cao TC, Weimer RM, Carano RA, van Bruggen N, Watts RJ.

Dev Cell. 2012 Feb 14;22(2):403-17. doi: 10.1016/j.devcel.2011.11.018.

4.

PET of glial metabolism using 2-18F-fluoroacetate.

Marik J, Ogasawara A, Martin-McNulty B, Ross J, Flores JE, Gill HS, Tinianow JN, Vanderbilt AN, Nishimura M, Peale F, Pastuskovas C, Greve JM, van Bruggen N, Williams SP.

J Nucl Med. 2009 Jun;50(6):982-90. doi: 10.2967/jnumed.108.057356. Epub 2009 May 14.

5.

Monocyte chemoattractant protein-1 or macrophage inflammatory protein-1alpha deficiency does not affect angiotensin II-induced intimal hyperplasia in carotid artery ligation model.

Zhang LN, da Cunha V, Martin-McNulty B, Rutledge J, Vergona R, Sullivan ME, Wang YX.

Cardiovasc Pathol. 2007 Jul-Aug;16(4):231-6. Epub 2007 Mar 21.

PMID:
17637431
6.

A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.

Wang YX, Vincelette J, da Cunha V, Martin-McNulty B, Mallari C, Fitch RM, Alexander S, Islam I, Buckman BO, Yuan S, Post JM, Subramanyam B, Vergona R, Sullivan ME, Dole WP, Morser J, Bryant J.

Thromb Haemost. 2007 May;97(5):847-55.

PMID:
17479197
7.

Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.

Martin-McNulty B, Zhang L, da Cunha V, Vincelette J, Rutledge JC, Vergona R, Sullivan ME, Wang YX.

Transl Res. 2007 Feb;149(2):70-5.

PMID:
17240317
8.

Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.

Wang YX, Wu C, Vincelette J, Martin-McNulty B, Alexander S, Larsen B, Light DR, McLean K.

Thromb Haemost. 2006 Sep;96(3):317-24.

PMID:
16953273
9.

Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis.

da Cunha V, Martin-McNulty B, Vincelette J, Choy DF, Li WW, Schroeder M, Mahmoudi M, Halks-Miller M, Wilson DW, Vergona R, Sullivan ME, Wang YX.

J Vasc Surg. 2006 Aug;44(2):364-71.

10.

Reduced cardiac functional reserve in apolipoprotein E knockout mice.

Vincelette J, Martin-McNulty B, Vergona R, Sullivan ME, Wang YX.

Transl Res. 2006 Jul;148(1):30-6.

PMID:
16887496
11.

Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice.

da Cunha V, Martin-McNulty B, Vincelette J, Zhang L, Rutledge JC, Wilson DW, Vergona R, Sullivan ME, Wang YX.

J Lipid Res. 2006 Mar;47(3):476-83. Epub 2005 Dec 21.

12.

Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system.

Martin-McNulty B, Vincelette J, Vergona R, Sullivan ME, Wang YX.

Ultrasound Med Biol. 2005 Jun;31(6):745-9.

PMID:
15936490
13.

Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.

Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, Feng Q, Halks-Miller M, Mahmoudi M, Schroeder M, Subramanyam B, Tseng JL, Deng GD, Schirm S, Johns A, Kauser K, Dole WP, Light DR.

Circulation. 2005 May 3;111(17):2219-26. Epub 2005 Apr 25.

PMID:
15851596
14.

Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.

Wang YX, da Cunha V, Martin-McNulty B, Vincelette J, Li W, Choy DF, Halks-Miller M, Mahmoudi M, Schroeder M, Johns A, Light DR, Dole WP.

Eur J Pharmacol. 2005 Apr 11;512(2-3):215-22.

PMID:
15840407
15.

Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.

da Cunha V, Tham DM, Martin-McNulty B, Deng G, Ho JJ, Wilson DW, Rutledge JC, Vergona R, Sullivan ME, Wang YX.

Atherosclerosis. 2005 Jan;178(1):9-17.

PMID:
15585195
16.

Lipopolysaccharide attenuates thrombolysis in batroxobin-induced lung vasculature fibrin deposition but not in ferrous chloride-induced carotid artery thrombus in rats: role of endogenous PAI-1.

Wang YX, Dong N, Wu C, Martin-McNulty B, Fitch RM, da Cunha V, Vicelette J, Tran K, Vergona R, Sullivan ME, Morser J, Wu Q.

Thromb Res. 2003;111(6):381-7.

PMID:
14698657
17.

Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.

Wu C, Dong N, da Cunha V, Martin-McNulty B, Tran K, Nagashima M, Wu Q, Morser J, Wang YX.

Thromb Haemost. 2003 Sep;90(3):414-21.

PMID:
12958609
18.

17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.

Martin-McNulty B, Tham DM, da Cunha V, Ho JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME, Wang YX.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1627-32. Epub 2003 Jul 10.

PMID:
12855485
19.

Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.

Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, Thinnes T, Loskutoff DJ, Carmeliet P, Dole WP, Wang YX.

Circ Res. 2003 Mar 21;92(5):510-7. Epub 2003 Feb 13.

PMID:
12600880
20.

Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice.

Tham DM, Martin-McNulty B, Wang YX, Da Cunha V, Wilson DW, Athanassious CN, Powers AF, Sullivan ME, Rutledge JC.

Am J Physiol Regul Integr Comp Physiol. 2002 Dec;283(6):R1442-9. Epub 2002 Sep 12.

21.

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.

Tham DM, Martin-McNulty B, Wang YX, Wilson DW, Vergona R, Sullivan ME, Dole W, Rutledge JC.

Physiol Genomics. 2002 Oct 2;11(1):21-30.

PMID:
12361987
22.
23.

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.

Wang YX, Martin-McNulty B, Huw LY, da Cunha V, Post J, Hinchman J, Vergona R, Sullivan ME, Dole W, Kauser K.

Atherosclerosis. 2002 May;162(1):23-31.

PMID:
11947894
24.

Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice.

Wang YX, Martin-McNulty B, Freay AD, Sukovich DA, Halks-Miller M, Li WW, Vergona R, Sullivan ME, Morser J, Dole WP, Deng GG.

Am J Pathol. 2001 Oct;159(4):1455-64.

25.

Hemodynamic changes in apolipoprotein E-knockout mice.

Hartley CJ, Reddy AK, Madala S, Martin-McNulty B, Vergona R, Sullivan ME, Halks-Miller M, Taffet GE, Michael LH, Entman ML, Wang YX.

Am J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2326-34.

26.

Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice.

Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, Mallari C, Martin-McNulty B, da Cunha V, Freay A, Rubanyi GM, Kauser K.

Am J Physiol Heart Circ Physiol. 2000 Feb;278(2):H428-34.

Supplemental Content

Loading ...
Support Center